Pier 88 Investment Partners LLC cut its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 10.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 45,240 shares of the company’s stock after selling 5,460 shares during the period. Pier 88 Investment Partners LLC’s […]